Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioxcel Therapeutics (BTAI)
:BTAI
RESEARCH TOOLSreports
Holding BTAI?
Track your performance easily
Bioxcel Therapeutics (BTAI) Ownership Overview
46.42% Insiders
4.16% Mutual Funds
0.10% Other Institutional Investors
2.55% ETFs
46.78% Public Companies and Individual Investors
The ownership structure of Bioxcel Therapeutics (BTAI) stock is a mix of institutional, retail, and individual investors. Approximately 6.81% of the company’s stock is owned by Institutional Investors, 46.42% is owned by Insiders, and 46.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 06, 2024 | Vimal Mehta Ceo & President,director, >10% Owner | xxxxxxxxxxxxx | $404505 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,901,750 | Insider | 30.10% | 3,169,023 | |
| 7,747,106 | Insider | 15.61% | 2,757,970 | |
| 1,179,567 | Institution | 2.38% | 419,926 | |
| 1,179,567 | Institution | 2.38% | 419,926 | |
| 605,841 | Institution | 1.22% | 215,679 | |
| 223,104 | Institution | 0.45% | 79,425 | |
| 209,795 | Insider | 0.42% | 74,687 | |
| 84,291 | Institution | 0.17% | 30,008 | |
| 29,713 | Institution | 0.06% | 10,578 | |
| 28,931 | Insider | 0.06% | 10,299 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,179,567 | Institution | 2.38% | 419,926 | |
| 605,841 | Institution | 1.22% | 215,679 | |
| 223,104 | Institution | 0.45% | 79,425 | |
| 29,713 | Institution | 0.06% | 10,578 | |
| 14,808 | Institution | 0.03% | 5,272 | |
| 13,911 | Institution | 0.03% | 4,952 | |
| 6,609 | Institution | 0.01% | 2,353 | |
| 2,135 | Institution | <0.01% | 760 | |
| 520 | Institution | <0.01% | 185 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 886,245 | Institution | 1.79% | 362,208 | |
| 293,322 | Institution | 0.59% | 119,881 | |
| 84,291 | Institution | 0.17% | 30,067 |
FAQ
Who Owns Bioxcel Therapeutics (BTAI)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 46.42% is held by insiders, and 46.78% is held by retail investors.
What percentage of Bioxcel Therapeutics (BTAI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.10% of Bioxcel Therapeutics (BTAI) stock is held by institutional investors.
What percentage of Bioxcel Therapeutics (BTAI) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.78% of Bioxcel Therapeutics (BTAI) stock is held by retail investors.
Who owns the most shares of Bioxcel Therapeutics (BTAI)?
Krishnan Nandabalan owns the most shares of Bioxcel Therapeutics (BTAI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.